Du H, Meng X, Yao Y, Xu J (2022) The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimers disease
They enhance insulin secretion in response to meals, suppress glucagon release, slow gastric emptying, and reduce appetite through central nervous system pathways
Gallbladder and Biliary Effects: A Murky Link GLP-1s slow gastric emptying, which helps with satietybut may also play a role in gallbladder issues
In mouse models of NASH, GLP-/GIP dual agonists have also been found to significantly reduce TG and LDL-C and increase high-density lipoprotein cholesterol (HDL-C) [127]
All compounds were prepared as solutions in isotonic saline and dosed as s.c
Put those four together consistently, and "why am I still hungry?" stops being the question